Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies - PubMed (original) (raw)
Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies
J Y Xu et al. J Virol. 1991 Sep.
Abstract
Immunogenic regions of the gp41 transmembrane protein of human immunodeficiency virus type 1 (HIV-1) were previously mapped by examining polyclonal sera from HIV-infected patients and rodent polyclonal and monoclonal antibodies (MAbs) to peptides of gp41. To define the epitopes within these regions to which infected humans respond during the course of infection, the specificity of human MAbs to these regions had to be studied. Using 10 human MAbs identified initially by their reactivity to whole gp41 in HIV-1 lysates, the epitopes within the immunodominant region of gp41 and within a second immunogenic region of gp41 have been mapped. Thus, five MAbs (from five different patients) to the immunodominant domain of gp41 in the vicinity of the cysteines at positions 598 and 604 (hereinafter designated cluster I) reacted with a stretch of 11 amino acids from positions 590 to 600. Four of these five MAbs were reactive with linear epitopes, while one MAb required the conformation conferred by the disulfide bridge between the aforementioned cysteines. Three MAbs to cluster I revealed dissociation constants ranging from 10(-6) to 10(-8) M, depending on the MAb tested and the size of the synthetic or recombinant peptide used in the assay. Five additional MAbs reacted with a second immunogenic region between positions 644 and 663 (designated cluster II). Four of these five MAbs were specific for conformational determinants. Titration of sera from HIV-infected patients showed that there was about 100-fold more antibody to cluster I than to cluster II in patients' sera, confirming the immunodominance of cluster I.
Similar articles
- Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.
Nyambi PN, Mbah HA, Burda S, Williams C, Gorny MK, Nádas A, Zolla-Pazner S. Nyambi PN, et al. J Virol. 2000 Aug;74(15):7096-107. doi: 10.1128/jvi.74.15.7096-7107.2000. J Virol. 2000. PMID: 10888650 Free PMC article. - Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
Viveros M, Dickey C, Cotropia JP, Gevorkian G, Larralde C, Broliden K, Levi M, Burgess A, Cao C, Weiner DB, Agadjanyan MG, Ugen KE. Viveros M, et al. Virology. 2000 Apr 25;270(1):135-45. doi: 10.1006/viro.2000.0269. Virology. 2000. PMID: 10772986 - Oligomer-specific conformations of the human immunodeficiency virus (HIV-1) gp41 envelope glycoprotein ectodomain recognized by human monoclonal antibodies.
Yuan W, Li X, Kasterka M, Gorny MK, Zolla-Pazner S, Sodroski J. Yuan W, et al. AIDS Res Hum Retroviruses. 2009 Mar;25(3):319-28. doi: 10.1089/aid.2008.0213. AIDS Res Hum Retroviruses. 2009. PMID: 19292593 Free PMC article. - Binding behaviour of antibodies reacting specifically with an immunodominant region of the transmembrane protein gp41 of HIV-1.
Döpel SH, Porstmann T, Grunow R, Henklein P, Pas P, von Baehr R. Döpel SH, et al. J Virol Methods. 1990 May;28(2):189-98. doi: 10.1016/0166-0934(90)90034-d. J Virol Methods. 1990. PMID: 1695222
Cited by
- Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies.
von Bredow B, Arias JF, Heyer LN, Moldt B, Le K, Robinson JE, Zolla-Pazner S, Burton DR, Evans DT. von Bredow B, et al. J Virol. 2016 Jun 10;90(13):6127-6139. doi: 10.1128/JVI.00347-16. Print 2016 Jul 1. J Virol. 2016. PMID: 27122574 Free PMC article. - Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection.
Alam SM, Scearce RM, Parks RJ, Plonk K, Plonk SG, Sutherland LL, Gorny MK, Zolla-Pazner S, Vanleeuwen S, Moody MA, Xia SM, Montefiori DC, Tomaras GD, Weinhold KJ, Karim SA, Hicks CB, Liao HX, Robinson J, Shaw GM, Haynes BF. Alam SM, et al. J Virol. 2008 Jan;82(1):115-25. doi: 10.1128/JVI.00927-07. Epub 2007 Oct 17. J Virol. 2008. PMID: 17942537 Free PMC article. - Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6.
Verrier F, Nádas A, Gorny MK, Zolla-Pazner S. Verrier F, et al. J Virol. 2001 Oct;75(19):9177-86. doi: 10.1128/JVI.75.19.9177-9186.2001. J Virol. 2001. PMID: 11533181 Free PMC article. - Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli.
Weissenhorn W, Calder LJ, Dessen A, Laue T, Skehel JJ, Wiley DC. Weissenhorn W, et al. Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6065-9. doi: 10.1073/pnas.94.12.6065. Proc Natl Acad Sci U S A. 1997. PMID: 9177169 Free PMC article.
References
- AIDS Res Hum Retroviruses. 1989 Aug;5(4):431-40 - PubMed
- Intervirology. 1990;31(6):327-38 - PubMed
- Cell. 1988 Jul 1;54(1):57-63 - PubMed
- Science. 1985 May 31;228(4703):1094-6 - PubMed
- AIDS. 1988 Apr;2(2):119-23 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources